Home/Filings/4/0001683168-24-005773
4//SEC Filing

Infarinato Robert M. 4

Accession 0001683168-24-005773

CIK 0001533040other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 4:14 PM ET

Size

5.2 KB

Accession

0001683168-24-005773

Insider Transaction Report

Form 4
Period: 2024-08-13
Infarinato Robert M.
VP, Chief Financial Officer
Transactions
  • Award

    Common stock, $0.0001 par value

    2024-08-13+8,0008,000 total
Footnotes (2)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments commencing on the first anniversary of the grant date.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Documents

1 file

Issuer

Phio Pharmaceuticals Corp.

CIK 0001533040

Entity typeother

Related Parties

1
  • filerCIK 0002032518

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:14 PM ET
Size
5.2 KB